Zobrazeno 1 - 10
of 50
pro vyhledávání: '"mitraClip procedure"'
Publikováno v:
Heart Views, Vol 24, Iss 3, Pp 160-162 (2023)
A 67-year-old man with inferior wall ST-segment elevation myocardial infarction underwent Impella-assisted percutaneous coronary intervention complicated by unilateral left-sided pulmonary edema and cardiogenic shock due to severe mitral valve regurg
Externí odkaz:
https://doaj.org/article/a75c823bb25a46e0bd0aecfbae158395
Autor:
Michael M. Kreusser, Andreas Weber, Nicolas A. Geis, Leonie Grossekettler, Martin J. Volz, Sonja Hamed, Hugo A. Katus, Sven T. Pleger, Norbert Frey, Philip W. Raake
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4617-4625 (2021)
Abstract Aim Percutaneous mitral valve repair (PMVR) via MitraClip implantation is a therapeutic option for severe mitral regurgitation (MR) in advanced stages of heart failure (HF). However, progressive left ventricular dilation in these patients ma
Externí odkaz:
https://doaj.org/article/001a7af3f19d4a869a816758b4af51fb
Autor:
Vien T. Truong, Tam N.M. Ngo, Jan Mazur, Hoai T.M. Nguyen, Thuy T.M. Pham, Cassady Palmer, Khanh N.P. Pham, Hoang T. Phan, Kwan S. Lee, Marwin Bannehr, Christian Butter, Takayuki Gyoten, Eugene S. Chung
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4988-4996 (2021)
Abstract Aim The objective of this study was to investigate the prognostic importance of right ventricular dysfunction (RVD) and tricuspid regurgitation (TR) in patients with moderate–severe functional mitral regurgitation (FMR) receiving MitraClip
Externí odkaz:
https://doaj.org/article/9f6365c7c9eb417890a53f19837d97c9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sankalp Sehgal, Monica Ahluwalia
Publikováno v:
Heart Views, Vol 19, Iss 4, Pp 141-145 (2018)
MitraClip procedure is an emerging minimally invasive technique for patients with severe mitral regurgitation (MR) who are at high risk for surgery. Transseptal puncture is a key step in MitraClip procedure that is usually performed superiorly and po
Externí odkaz:
https://doaj.org/article/e6f415f1532b4f26b73ed29235ff6456
Autor:
Gloria Tamborini, Valentina Mantegazza, Anna Garlaschè, Manuela Muratori, Laura Fusini, Sarah Ghulam Ali, Claudia Cefalù, Gianpiero Italiano, Paola Gripari, Anna Maltagliati, Marco Penso, Mauro Pepi
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 7, p 73 (2021)
MitraClip (MC) is the most common percutaneous treatment for severe mitral regurgitation (MR). An accurate two-dimensional and three-dimensional echocardiographic (3DTEE) imaging is mandatory for the optimal procedural result. Recently transilluminat
Externí odkaz:
https://doaj.org/article/b587dbf78554405e9cb67aef2e1f4230
Autor:
Norbert Frey, Nicolas A. Geis, Hugo A. Katus, Sven T. Pleger, Andreas Weber, Leonie Grossekettler, Sonja Hamed, Philip Raake, Martin J Volz, Michael M. Kreusser
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4617-4625 (2021)
ESC Heart Failure
ESC Heart Failure
Aim Percutaneous mitral valve repair (PMVR) via MitraClip implantation is a therapeutic option for severe mitral regurgitation (MR) in advanced stages of heart failure (HF). However, progressive left ventricular dilation in these patients may lead to
Autor:
Cassady Palmer, Jan Mazur, Marwin Bannehr, Khanh N.P. Pham, Christian Butter, Takayuki Gyoten, Vien T. Truong, Thuy T M Pham, Hoai T M Nguyen, Eugene S. Chung, Tam N M Ngo, Hoang T Phan, Kwan S Lee
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 6, Pp 4988-4996 (2021)
ESC Heart Failure, Vol 8, Iss 6, Pp 4988-4996 (2021)
Aim The objective of this study was to investigate the prognostic importance of right ventricular dysfunction (RVD) and tricuspid regurgitation (TR) in patients with moderate–severe functional mitral regurgitation (FMR) receiving MitraClip procedur
Publikováno v:
Netherlands Heart Journal
Although mitral regurgitation (MR) is the most common valvular heart disease, it should be regarded as a complex multifactorial disease that involves multiple entities. Optimal medical therapy alone does not hinder the progression of the disease, and
Publikováno v:
Netherlands Heart Hournal. 28(5):266-271
Although mitral regurgitation (MR) is the most common valvular heart disease, it should be regarded as a complex multifactorial disease that involves multiple entities. Optimal medical therapy alone does not hinder the progression of the disease, and